🇺🇸 FDA

Drug profile · INN

pneumococcal polysaccharide conjugate vaccine (20-valent, adsorbed)

PREVENAR 20 (PREVIOUSLY APEXXNAR)

EMA: approved J07AL02
Patents linked
0
News articles
0

Quick answer

pneumococcal polysaccharide conjugate vaccine (20-valent, adsorbed) (PREVENAR 20 (PREVIOUSLY APEXXNAR)) is an FDA-listed pharmaceutical active ingredient.

Key facts

INN pneumococcal polysaccharide conjugate vaccine (20-valent, adsorbed)
Brand PREVENAR 20 (PREVIOUSLY APEXXNAR)
ATC code J07AL02

Frequently asked questions

What is pneumococcal polysaccharide conjugate vaccine (20-valent, adsorbed)?

pneumococcal polysaccharide conjugate vaccine (20-valent, adsorbed) (PREVENAR 20 (PREVIOUSLY APEXXNAR)) is an FDA-listed pharmaceutical active ingredient.

What is the brand name for pneumococcal polysaccharide conjugate vaccine (20-valent, adsorbed)?

PREVENAR 20 (PREVIOUSLY APEXXNAR) is a marketed brand name for pneumococcal polysaccharide conjugate vaccine (20-valent, adsorbed). Check FDA Drugs@FDA for the current US label holder and prescribing information.